Use of N-(dibenz (B,F)oxepin-10-ylmethyl)-N-methyl-N-pr op-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy

Details for Australian Patent Application No. 2006284140 (hide)

Owner Santhera Pharmaceuticals (Schweiz) AG

Inventors Ruegg, Markus A.; Meier, Thomas

Agent Shelston IP

Pub. Number AU-B-2006284140

PCT Pub. Number WO2007/022951

Priority 05018530.5 25.08.05 EP

Filing date 22 August 2006

Wipo publication date 1 March 2007

Acceptance publication date 20 August 2009

International Classifications

A61K 31/335 (2006.01) - having oxygen as the only ring hetero atom, e.g. fungichromin

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/022951 Priority application(s): WO2007/022951

20 August 2009 Application Accepted

  Published as AU-B-2006284140

17 December 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006284165-Sterol ester powder

2006284134-Multicoordinated metal complexes for use in metathesis reactions